1. Denmark Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Novo Nordisk A/S Class B

Novo Nordisk A/S Class B

285.20
DKK
+15.05
(+5.57%)
26.20EPS
11.99P/E
1.39TMarket Cap
Feb 03Next Earn

Novo Nordisk A/S Class B Documents

Q1 FY2025 · Interim report

Novo Nordisk - Q1 2025 - Interim report · May 7, 2025 · 36 pages

Read Novo Nordisk A/S Class B's results firsthand

Preview the first 2 pages of this interim report
Create a free account to start reading

Full documents are included with Professional

Q1 FY2025 documents

Interim report

Novo Nordisk - Q1 2025 - Interim report

36 pages

May 7, 2025

Interim report

36 pages

May 7, 2025

Presentation

173 pages

Presentation

20250516_Slides_for_Conference_Call (1)

1 page

Presentation

Novo Nordisk A_S - Special Call

58 pages

Presentation

944b8-2025-05-07-10-04-15 (1)

173 pages

Press release

3 pages

May 16, 2025

Q1 FY2025 earnings call →